Government Support for RPM in Health Care vs Payer Rollbacks: Which Drives Better Care?

Government support for remote patient monitoring (RPM) currently delivers more consistent, equitable care than the recent payer rollbacks that threaten coverage.

In 2026 UnitedHealthcare announced a rollback of RPM coverage, citing a lack of evidence (Mario Aguilar).

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Government Support for RPM in Health Care

Here’s the thing - the Australian government has poured money into digital health programmes since the COVID-19 surge, and those funds are still flowing. The My Health Record platform now integrates RPM data from approved devices, allowing clinicians to view blood pressure, glucose and weight trends without the patient stepping into a clinic. In my experience around the country, especially in remote Aboriginal communities, this integration has cut travel time for patients by up to half.

From a policy perspective, the Department of Health allocated $170 million in the 2023-24 budget to expand RPM services for chronic disease management (Australian Government). That money supports pilot projects in Queensland, Victoria and the ACT, where community health workers are trained to set up Bluetooth-enabled monitors and feed data into the national EHR. The aim is to reduce hospital admissions for heart failure, COPD and diabetes - conditions that cost the health system over $2 billion a year (AIHW). By subsidising the devices and providing rebates for clinicians, the government removes the cost barrier that many private insurers have re-introduced.

When I reported from a regional NSW clinic in early 2024, I saw a nurse use a simple pulse oximeter linked to the clinic’s dashboard. The data triggered an early intervention that prevented a potentially life-threatening exacerbation. The nurse told me the RPM rebate made the device affordable for the practice, something that would have been impossible if a private payer had withdrawn support.

1. Funding Streams: Federal budget allocations, state-level grants, and Medicare rebates for RPM services.
2. Regulatory Framework: Australian Digital Health Agency standards ensure data security and interoperability.
3. Provider Incentives: Medicare items 715 and 716 reimburse clinicians for remote monitoring set-up and review.
4. Patient Access: Subsidised devices for low-income households through the Chronic Disease Management Programme.
5. Outcome Metrics: Early data show a 12% reduction in unplanned admissions where RPM is fully implemented (AIHW).

Key Takeaways

• Government rebates keep RPM affordable for patients.
• State pilots are proving clinical benefits.
• Data integration via My Health Record improves coordination.
• Early evidence shows fewer hospital readmissions.
• Provider incentives drive adoption.

Payer Rollbacks on Remote Patient Monitoring

Look, the private insurance market in the US has taken a hard turn, and that ripple reaches Australian stakeholders who watch overseas trends. UnitedHealthcare’s 2026 decision to pause RPM coverage was framed as “no evidence of cost savings,” even though multiple studies - including a 2023 European review - found reduced readmission rates (Frontiers). The move sent a warning signal to other payers that device-only programmes, especially those without a human-in-the-loop, might not survive.

In my experience, when insurers pull back, providers scramble to find alternative funding. That often means scaling back RPM programmes, limiting them to high-risk patients, or dropping them altogether. A recent survey of Australian private health funds (ArentFox Schiff) showed that 38% are reviewing their RPM clauses, with many planning stricter utilisation reviews. The risk is a two-tier system: patients with private cover keep access, while those relying on Medicare may see gaps if government funding does not keep pace.

The rollout of virtual caregiver platforms, like Addison(R) Virtual Caregiver, is an attempt to sidestep the device-only model by adding 24/7 human support. Yet without consistent payer reimbursement, such services struggle to reach scale. In the US, UnitedHealthcare’s rollback has already led some clinics to stop accepting RPM-related billing codes, effectively removing the service for many patients.

• Coverage Uncertainty: Private insurers may drop RPM if they deem it non-essential.
• Administrative Burden: Providers face more paperwork to justify RPM under stricter payer rules.
• Equity Risks: Patients without private cover could lose access.
• Innovation Stifling: Companies may hesitate to invest in new RPM tech without reliable reimbursement.
• Potential Cost Shifts: Savings from avoided hospitalisations could be lost if RPM is under-utilised.

Practical Take: Which Drives Better Care?

In my nine years reporting on health policy, I’ve seen two forces shape the future of remote monitoring: government backing that builds an ecosystem, and payer decisions that can either sustain or cripple it. The evidence suggests that a coordinated, publicly funded approach yields steadier outcomes. When the Commonwealth puts money behind RPM, clinicians get the tools, patients get the devices, and data flows into the national record - all without the unpredictability of private contracts.

That’s not to say private insurers have no role. They can accelerate adoption through innovative value-based contracts, but only if those contracts align with the broader public health agenda. The UnitedHealthcare rollback illustrates what happens when a major payer pulls the plug - providers lose revenue, patients lose continuity, and the promise of RPM stalls.

For Australian health services, the takeaway is simple: keep the funding stream stable, protect the rebates, and let the data sit in My Health Record where every clinician can see it. If we let payer rollbacks dictate the rules, we risk a fragmented system that favours the well-insured and leaves the most vulnerable behind.

1. Maintain Federal Funding: Secure annual budget lines for RPM pilots.
2. Protect Medicare Items: Ensure items 715/716 remain reimbursable.
3. Encourage State Collaboration: Share lessons from Queensland and ACT pilots.
4. Integrate Human Support: Pair devices with virtual caregivers to meet payer expectations.
5. Monitor Outcomes: Use AIHW data to track readmissions and cost savings.
6. Advocate Against Rollbacks: Lobby insurers to keep RPM covered when evidence shows benefit.
7. Educate Clinicians: Provide training on data interpretation and billing.
8. Expand Patient Subsidies: Target low-income and rural households.
9. Standardise Data: Align device formats with the Australian Digital Health Agency standards.
10. Foster Public-Private Partnerships: Use private innovation while keeping public reimbursement stable.

Frequently Asked Questions

Q: What is remote patient monitoring (RPM)?

A: RPM uses digital devices to collect health data like blood pressure or glucose levels at home, sending it to clinicians for ongoing review without an in-person visit.

Q: How does the Australian government support RPM?

A: Through budget allocations, Medicare rebate items for set-up and review, and integration of RPM data into My Health Record, the government funds devices and clinician time.

Q: Why are some insurers pulling back RPM coverage?

A: Insurers like UnitedHealthcare claim insufficient evidence of cost-savings and prefer to focus on higher-value services, leading them to pause or tighten RPM reimbursements.

Q: What evidence exists that RPM improves outcomes?

A: AIHW data shows a 12% reduction in unplanned admissions where RPM is fully integrated, and international studies report similar trends in chronic disease management.

Q: How can providers sustain RPM if insurers cut back?

A: Providers can rely on government rebates, join state pilot programmes, and incorporate virtual caregiver services that qualify for existing Medicare items.